Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a small behind-the-scenes update to the page template.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor page update without changes to the study content. This likely represents backend refinements rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-10T12:09:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated to Revision: v3.6.4, and the previous Revision: v3.6.3 tag has been removed. This represents a new version of the page without changes to the core study content.
    Difference
    0.0%
    Check dated 2026-07-27T06:16:20.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.3, indicating a newer version of the page or template. This change does not alter the study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-07-05T13:35:37.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants,' indicating that recruitment for the study has closed.
    Difference
    0.4%
    Check dated 2026-06-14T03:59:34.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a new page build; the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-06T23:39:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.